1. Home
  2. ROIV vs DRI Comparison

ROIV vs DRI Comparison

Compare ROIV & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$34.40

Market Cap

25.1B

Sector

Health Care

ML Signal

HOLD

Logo Darden Restaurants Inc.

DRI

Darden Restaurants Inc.

HOLD

Current Price

$214.75

Market Cap

25.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
DRI
Founded
2014
1968
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
25.1B
25.9B
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
ROIV
DRI
Price
$34.40
$214.75
Analyst Decision
Strong Buy
Buy
Analyst Count
9
25
Target Price
$28.94
$226.50
AVG Volume (30 Days)
7.1M
802.2K
Earning Date
05-28-2026
03-19-2026
Dividend Yield
N/A
3.06%
EPS Growth
N/A
17.16
EPS
N/A
10.38
Revenue
$8,260,000.00
$13,210,900,000.00
Revenue This Year
N/A
$10.58
Revenue Next Year
$744.61
$3.73
P/E Ratio
N/A
$20.65
Revenue Growth
N/A
9.39
52 Week Low
$12.28
$169.00
52 Week High
$37.97
$229.76

Technical Indicators

Market Signals
Indicator
ROIV
DRI
Relative Strength Index (RSI) 45.18 50.05
Support Level $33.01 $190.21
Resistance Level $35.70 $220.00
Average True Range (ATR) 1.12 5.14
MACD -0.29 -1.43
Stochastic Oscillator 20.61 21.37

Price Performance

Historical Comparison
ROIV
DRI

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About DRI Darden Restaurants Inc.

Darden Restaurants is the largest global full-service dining operator, with over $12 billion in system sales across 2,159 company-owned stores at the end of fiscal 2025, spanning the US and Canada. The firm operates 10 banners in four segments, including Olive Garden (43% of sales), LongHorn Steakhouse (25%), and fine dining (21%), which includes The Capital Grille, Ruth's Chris, and Eddie V's. The other 11% of sales comes from smaller concepts such as Yard House and Cheddar's. Darden primarily generates revenue through sales of food and beverage items at its company-owned restaurants. It also earns royalties on sales from 154 franchised locations in US and international markets, which sit within the other segment but are immaterial to consolidated results.

Share on Social Networks: